Valuation: GENFIT

Market Cap 715M 835M 670M 612M 1.16B 79.59B 1.17B 7.91B 3.08B 40.15B 3.13B 3.07B 133B P/E 2026 *
36.9x
P/E 2027 * 95x
Enterprise Value 664M 775M 622M 569M 1.07B 73.9B 1.08B 7.34B 2.86B 37.28B 2.91B 2.85B 123B EV / Sales 2026 *
6.63x
EV / Sales 2027 * 5.23x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.56%
1 week-1.25%
Current month-3.00%
1 month+4.25%
3 months+66.71%
6 months+60.77%
Current year+170.09%
1 week 13.56
Extreme 13.56
14.82
1 month 12.74
Extreme 12.74
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
12/7/23 Buy

Director

5,300 0.0106%
7/7/23 Buy

Chief Executive Officer

10,000 0.0201%
7/7/23 Buy

Founder

10,000 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-0.56%-1.25%+303.29%+334.20% 835M
-1.01%+1.48%+1.66%+23.62% 51.65B
+1.06%-0.70%+471.87%+560.77% 45.31B
+0.89%+4.75%+39.08%+17.74% 42.7B
-0.22%-0.80%+21.03%+85.00% 42.79B
-2.27%-3.02%+14.22%+51.50% 32.87B
+0.69%+1.19%+31.16%+135.25% 17.14B
-0.76%-3.62% - - 16.61B
-1.70%+3.06%+11.11%+28.57% 15.01B
+0.16%+2.33%+81.27%+49.31% 14.21B
Average -0.34%+3.10%+108.30%+142.88% 27.91B
Weighted average by Cap. -0.24%+2.74%+101.36%+138.81%

Financials

2026 *2027 *
Net sales 100M 117M 93.89M 85.76M 162M 11.15B 163M 1.11B 431M 5.62B 439M 429M 18.63B 124M 145M 116M 106M 200M 13.8B 202M 1.37B 534M 6.96B 544M 532M 23.06B
Net income 22.88M 26.7M 21.44M 19.58M 36.95M 2.55B 37.32M 253M 98.44M 1.28B 100M 98.06M 4.25B 6.8M 7.94M 6.37M 5.82M 10.98M 757M 11.09M 75.16M 29.26M 382M 29.8M 29.15M 1.26B
Net Debt -51.12M -59.65M -47.9M -43.75M -82.57M -5.69B -83.38M -565M -220M -2.87B -224M -219M -9.5B -66.17M -77.22M -62.01M -56.64M -107M -7.36B -108M -731M -285M -3.71B -290M -284M -12.3B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
27/08/26 EUR 14.22 -0.56% 246,222
25/08/26 EUR 14.30 +2.88% 190,089
24/08/26 EUR 13.90 -3.61% 227,083
21/08/26 EUR 14.42 +2.27% 206,111
20/08/26 EUR 14.10 -2.08% 307,015
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.30EUR
Average target price
15.90EUR
Spread / Average Target
+11.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock